Structure/Function Claim Proposed Reg Creates Research Disincentive - RDIA
This article was originally published in The Tan Sheet
Executive Summary
FDA's definition of disease in its proposed rule on appropriate structure/function claims is "inconsistent with current medical practice and understanding," the Research-based Dietary Ingredient Association says in Sept. 25 comments to the agency.